gene g kinney addedit   you are here scientific experts  usa  merck research laboratories  kinney  gene g kinney research topicsglycinephenylacetatesn methyl d aspartate receptorssarcosinephencyclidinelong term potentiationproto oncogene proteins c fosneutral amino acid transport systemsinbred dba micemetabotropic glutamate receptorsexcitatory amino acid antagonistsexcitatory amino acid agonistspsychomotor performancebiological transportmotor activityneural inhibitionpyridinesantipsychotic agentsanimal behaviorsynapsesexcitatory amino acid agentsknockout micesynaptic transmissionschizophreniainbred cbl micehippocampusalpha amino  hydroxy  methyl  isoxazolepropionic acidcalcineurinampa receptorsendocytosisgenomes and genesgrm productsgrm productsgrm productsapp productsgrm productsspeciesratmousegene g kinneysummaryaffiliation merck research laboratoriescountry usapublications metabotropic glutamate subtype  receptors modulate locomotor activity and sensorimotor gating in rodentsgene g kinneydepartment of neuroscience merck west point pa  usaj pharmacol exp ther   the glycine transporter type  inhibitor nfluorophenylphenylphenoxypropylsarcosine potentiates nmda receptormediated responses in vivo and produces an antipsychotic profile in rodent behaviorgene g kinneydepartment of neuroscience merck research laboratories west point pennsylvania  usaj neurosci 7  discovery of glyt inhibitors with improved pharmacokinetic propertiesscott e wolkenbergdepartment of medicinal chemistry technology enabled synthesis group merck and co inc po box  west point pa  usabioorg med chem lett   a novel selective positive allosteric modulator of metabotropic glutamate receptor subtype  has in vivo activity and antipsychoticlike effects in rat behavioral modelsgene g kinneyneuroscience west point merck research laboratories west point pa  usaj pharmacol exp ther   progress towards validating the nmda receptor hypofunction hypothesis of schizophreniacraig w lindsleydepartment of medicinal chemistry merck research laboratories merck and co po box  west point pa  usacurr top med chem 77  discovery of nbenzamides as novel selective and potent glyt inhibitorszhijian zhaodepartment of medicinal chemistry technology enabled synthesis group merck and co inc wp   po box  sumneytown pike west point pa  usabioorg med chem lett  these inhibitors are devoid of timedependent cyp inhibition activity and exhibit improved aqueous solubility versus the corresponding phenylpiperidine analogues design synthesis and in vivo efficacy of glycine transporter glyt inhibitors derived from a series of phenylpropylsulfonylpiperidinylmethyl benzamidescraig w lindsleydepartment of medicinal chemistry technology enabled synthesis group merck research laboratories p o box  west point pa  usachemmedchem   discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype  from a series of ndiphenylh pyrazolylbenzamides that potentiate receptor function in vivocraig w lindsleydepartment of medicinal chemistry technology enabled synthesis group department of neuroscience department of drug metabolism merck research laboratories west point pennsylvania  usaj med chem 7 compound q demonstrated in vivo proof of concept in an animal behavior model where known antipsychotics are active supporting the development of new antipsychotics based on the nmda hypofunction model for schizophrenia the mglur antagonist methylphenylethynylpyridine mpep potentiates pcpinduced cognitive deficits in ratsuna c campbelldepartment of pharmacology merck research laboratories san diego ca  usapsychopharmacology berl 7 for example the mglur antagonist methylphenylethynylpyridine mpep can potentiate pcp phencyclidineevoked hyperactivity and pcpinduced disruptions in prepulse inhibition ppi in rats allosteric modulation of group iii metabotropic glutamate receptor  a potential approach to parkinsons disease treatmentmichael j marinodepartment of neuroscience merck research laboratories west point pa  usaproc natl acad sci u s a 7 these results are evidence for in vivo behavioral effects of an allosteric potentiator of mglurs and suggest that potentiation of mglur may be a useful therapeutic approach to the treatment of pd group iii metabotropic glutamate receptormediated modulation of the striatopallidal synapseornella valentidepartment of neuroscience merck research laboratories west point pennsylvania   usaj neurosci 7 consistent with this we find that intracerebroventricular injections of lap produce therapeutic benefit in both acute and chronic rodent models of parkinsons disease amphetamineinduced locomotor activity is reduced in mice following mptp treatment but not following selegilinemptp treatmentbrian d westneuroscience drug discovery merck research laboratories p o box  wpe  west point pa  usapharmacol biochem behav  further the potential for use of this endpoint to evaluate putative therapeutics is exemplified by the amelioration of these effects following pretreatment with the maob inhibitor selegiline progress in the preparation and testing of glycine transporter type glyt inhibitorscraig w lindsleymedicinal chemistry merck research laboratories west point pa  usacurr top med chem   glycine transporter  inhibitors and modulation of nmda receptormediated excitatory neurotransmissioncyrille surdepartment of imaging and neuroscience drug discovery merck research laboratories west point pa  usacurr drug targets  7 the therapeutic potential of glycine transporter inhibitorscyrille surdepartment of neuroscience merck research laboratories wpe  west point pa  usaexpert opin investig drugs   inhibition of calcineurinmediated endocytosis and alphaaminohydroxymethylisoxazolepropionic acid ampa receptors prevents amyloid beta oligomerinduced synaptic disruptionwei qin zhaodepartment of neurology merck research laboratories west point pennsylvania  usaj biol chem 7 validation of this model in human disease would identify therapeutic targets for alzheimer disease the role of amyloidbeta derived diffusible ligands addls in alzheimers diseasesusan m catalanodepartment of alzheimer s research merck research laboratories west point pa  usacurr top med chem 7 possible therapeutic approaches aimed at lowering addls in ad patients are also considered alzheimers diseasetype neuronal tau hyperphosphorylation induced by a beta oligomersfernanda g de felicedepartment of neurobiology and physiology northwestern university  tech drive evanston il  usaneurobiol aging 7 a beta oligomers have been increasingly implicated as the main neurotoxins in ad and the current results provide a unifying mechanism in which oligomer activity is directly linked to tau hyperphosphorylation in ad pathology snmorpholinylphenylethyl phenylacrylamide an orally bioavailable kcnq opener with significant activity in a cortical spreading depression model of migraineyong jin wubristol myers squibb pharmaceutical research institute  research parkway wallingford connecticut  usaj med chem 7 in a rat model of migraine  demonstrated significant oral activity in reducing the total number of cortical spreading depressions induced by potassium chloride   labomeorg   all rights researvedprinceton new jersey  usalast updated december 7  gene g kinney  director president  chief executive officer at prothena corp plc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink gene g kinney director president  chief executive officer at prothena corp plc overview in the news relationships paths education career history boards  committees public holdings gene g kinney director president  chief executive officer at prothena corp plc overview age  born  notable companies prothena corp plc board seats  number of relationships this person is connected to  people in the news see more thomson reuters one july  7 prothena announces initiation of phase  pasadena study of prxrg7 in patients with early parkinsons disease thomson reuters one june  7 prothena announces appointment of wagner zago phd as chief scientific officer thomson reuters one may  7 prothena announces appointment of sarah noonberg md phd as chief medical officer thomson reuters one may  7 prothena reports first quarter 7 financial results and provides rd update cnbc april  7 drug companies risk trumps wrath as they march for science see full news coverage and complete stories with relsci professional create your news feed see more relationships see details richard t collier adjunct professor of law at temple university  james e beasley school of law lars ekman executive partner private equity at sofinnova ventures inc christopher s henney former interim chief executive officer at cascadian therapeutics inc dennis j selkoe codirectorneurologic diseases center at the brigham  womens hospital inc shane m cooke president at alkermes plc karl anders olof härfstrand former chief executive officer  director at horizon pharma ag anders o harfstrand independent director at prothena corp plc tran nguyen chief financial officer at prothena corp plc wagner zago chief scientific officer at prothena corp plc tara nickerson chief business officer at prothena corp plc see  more listings with relsci professional start my free trial ➤ see  more paths to gene g kinney gene g kinney you connections via relationship science gene g kinney sync your contacts to see how you can connect with gene g kinney start my free trial ➤ see more educational background   florida atlantic university florida atlantic university also referred to as fau or florida atlantic is a public university located in boca raton florida with five satellite campuses located in the florida cities of dania beach davie fort lauderdale jupiter and in fort pierce at the harbor branch oceanographic institution fau belongs to the campus state university system of florida and serves south florida which has a population of more than three million people and spans more than  miles  km of coastline   bloomsburg university of pennsylvania career history director president  chief executive officer   current prothena corp plc prothena corp plc is a clinical stage biotechnology company which engages in the discovery development and commercialization of novel antibodies its antibodybased product candidates target a number of potential indications including al amyloidosis neod parkinsons disease and related synucleinopathies prx inflammatory diseases including psoriasis psoriatic arthritis prx and attr amyloidosis prx the company was founded on december   and is headquartered in dun laoghaire ireland senior vice presidentpharmacological sciences    elan pharmaceuticals inc elan pharmaceuticals inc develops and manufactures pharmaceutical products it specializes in treatment of neurological and autoimmune diseases the firms drugs are used in the treatment of for alzheimers parkinsons and rheumatoid arthritis diseases the company is headquartered in south san francisco ca headnonclinical research prior janssen alzheimer immunotherapy assistant professor prior emory university  emory school of medicine emory university school of medicine is the graduate medical school of emory university and a component of emory’s robert w woodruff health sciences center  emory university school of medicine traces its origins back to  when the atlanta medical college founded  the southern medical college 7 and the atlanta school of medicine founded  merged boards  committees corporate boards ▾ director president  chief executive officer   current prothena corp plc prothena corp plc is a clinical stage biotechnology company which engages in the discovery development and commercialization of novel antibodies its antibodybased product candidates target a number of potential indications including al amyloidosis neod parkinsons disease and related synucleinopathies prx inflammatory diseases including psoriasis psoriatic arthritis prx and attr amyloidosis prx the company was founded on december   and is headquartered in dun laoghaire ireland public holdings restricted data only for relsci professional users start my free trial ➤ see more other affiliations gene g kinney is affiliated with prothena corp plc elan pharmaceuticals inc janssen alzheimer immunotherapy emory university  emory school of medicine prothena corp plc youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ prothena announces appointment of gene g kinney as chief operating officer nasdaqprta facebook google linkedin twitter email rss sep   previous release  next release pdf add to briefcase file is in briefcase prothena announces appointment of gene g kinney as chief operating officer dublin ireland sept   globe newswire  prothena corporation plc nasdaqprta a latestage clinical biotechnology company focused on the discovery development and commercialization of novel protein immunotherapies today announced the promotion of gene g kinney phd to the position of chief operating officer coo in this newly created position dr kinney will be responsible for an integrated research development and commercial organization and several additional key organizational functions within the company dr kinney also retains his title and responsibilities as chief scientific officer dr kinney had held the position of chief scientific officer and head of research and development since prothena was established in december  leading the team responsible for advancing a robust clinical pipeline into latestage clinical development as well as generating novel antibody targets in discovery genes appointment to this expanded role underscores not only his exceptional scientific and business leadership but also the exciting growth path we are setting for prothena commented dale schenk phd president and chief executive officer of prothena as one of our founding executive team members responsible for helping to establish the company and advance a pipeline of novel protein immunotherapies gene is uniquely qualified to guide our continued growth as a fully integrated research development and commercial organization i very much look forward to working with him on these critical efforts gene is a highly regarded creative and thoughtful leader who has played a key role in the success prothena has experienced to date noted lars g ekman md phd chairman of the prothena board of directors the prothena board is delighted to continue working with gene in this new leadership role dr kinney is an experienced biotechnology executive and has held positions across pharmaceutical biotechnology and academic organizations in positions of increasing scope dr kinney has held responsibility for overseeing portfolio strategy leading rd teams and supporting commercial product launches before joining prothena dr kinney was senior vice president of pharmacological sciences at elan pharmaceuticals inc where he held several senior roles in research and development from  through  between  and  dr kinney also served as head of nonclinical research for janssen alzheimer immunotherapy rd from  to  he was senior director head of central pharmacology and acting lead for bioanalytics  pathology at merck research laboratories dr kinney also held positions at bristolmyers squibb and was an assistant professor at the emory university school of medicine department of psychiatry and behavioral sciences dr kinney earned his ba from bloomsburg university and his ma and phd from florida atlantic university about prothena prothena corporation plc is a global latestage clinical biotechnology company seeking to fundamentally change the course of progressive diseases with its clinical pipeline of novel therapeutic antibodies fueled by its deep scientific understanding built over decades of research in protein misfolding and cell adhesion — the root causes of many serious or currently untreatable amyloid and inflammatory diseases — prothena has advanced several drug candidates into clinical trials while pursuing discovery of additional novel therapies  our pipeline of antibodybased product candidates targets a number of potential indications including al amyloidosis neod parkinsons disease and other related synucleinopathies prx and inflammatory diseases including psoriasis prx and attr amyloidosis prx for more information please visit the companys web site at wwwprothenacom investors tran nguyen cfo 7 irprothenacom media ellen rose  ellenroseprothenacom prothena announces appointment of gene g kinney as chief operating officerhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hr  minssp futures7 dow futures nasdaq futures prothena announces appointment of gene g kinney as chief operating officerglobenewswire•september  reblogsharetweetsharedublin ireland sept   globe newswire  prothena corporation plc prta a latestage clinical biotechnology company focused on the discovery development and commercialization of novel protein immunotherapies today announced the promotion of gene g kinney phd to the position of chief operating officer coo in this newly created position dr kinney will be responsible for an integrated research development and commercial organization and several additional key organizational functions within the company dr kinney also retains his title and responsibilities as chief scientific officer dr kinney had held the position of chief scientific officer and head of research and development since prothena was established in december  leading the team responsible for advancing a robust clinical pipeline into latestage clinical development as well as generating novel antibody targets in discoverygenes appointment to this expanded role underscores not only his exceptional scientific and business leadership but also the exciting growth path we are setting for prothena commented dale schenk phd president and chief executive officer of prothena as one of our founding executive team members responsible for helping to establish the company and advance a pipeline of novel protein immunotherapies gene is uniquely qualified to guide our continued growth as a fully integrated research development and commercial organization i very much look forward to working with him on these critical effortsgene is a highly regarded creative and thoughtful leader who has played a key role in the success prothena has experienced to date noted lars g ekman md phd chairman of the prothena board of directors the prothena board is delighted to continue working with gene in this new leadership roledr kinney is an experienced biotechnology executive and has held positions across pharmaceutical biotechnology and academic organizations in positions of increasing scope dr kinney has held responsibility for overseeing portfolio strategy leading rd teams and supporting commercial product launches before joining prothena dr kinney was senior vice president of pharmacological sciences at elan pharmaceuticals inc where he held several senior roles in research and development from  through  between  and  dr kinney also served as head of nonclinical research for janssen alzheimer immunotherapy rd from  to  he was senior director head of central pharmacology and acting lead for bioanalytics  pathology at merck research laboratories dr kinney also held positions at bristolmyers squibb and was an assistant professor at the emory university school of medicine department of psychiatry and behavioral sciencesdr kinney earned his ba from bloomsburg university and his ma and phd from florida atlantic universityabout prothenaprothena corporation plc is a global latestage clinical biotechnology company seeking to fundamentally change the course of progressive diseases with its clinical pipeline of novel therapeutic antibodies fueled by its deep scientific understanding built over decades of research in protein misfolding and cell adhesion  the root causes of many serious or currently untreatable amyloid and inflammatory diseases  prothena has advanced several drug candidates into clinical trials while pursuing discovery of additional novel therapies  our pipeline of antibodybased product candidates targets a number of potential indications including al amyloidosis neod parkinsons disease and other related synucleinopathies prx and inflammatory diseases including psoriasis prx and attr amyloidosis prx for more information please visit the companys web site at wwwprothenacominvestors tran nguyen cfo7 irprothenacommedia ellen rose ellenroseprothenacomthis announcement is distributed by nasdaq omx corporate solutions on behalf of nasdaq omx corporate solutions clientsthe issuer of this announcement warrants that they are solely responsible for the content accuracy and originality of the information contained thereinsource prothena corporation plc via globenewswirehugreblogsharetweetsharerecently viewedyour list is emptywhat to read nextgrab builds out war chest in a fight for carshare dominanceassociated pressengineer finds pattern makes millions in stocksmoney morningsponsoredheres trumps approval rating in every statebusiness insiderparents railed against the boy scouts of america after trumps campaignstyle speechbusiness insiderthe navys newest most sophisticated aircraft carrier doesnt have urinalsbusiness insiderstart earning miles with the best travel cardwise breadsponsoredchina is crushing american tech titansyahoo finance videomcdonalds gm and dominos — what you need to know in markets on tuesdayyahoo financefirst ‘avengers infinity war’ trailer leakedinvestorplacedog gets on bus alone every day without ownernews daily feedsponsoredobamacare is hurting these people—and congress is doing nothing about ityahoo financeunder armour ripped up jordan spieths old contract before he won his first major and gave him a year deal and its already paid off big timebusiness insidergoogles forward guidance trumps earnings any day nyse traderyahoo finance videohitlers final bunker broken into by photographertrend chasersponsoredstocks rangebound ahead of big earningsyahoo financecaterpillar beats estimates bumps up forecastreutersrepublicans in house push for congressional budget office cutsliberaltroll so the new republican slogan is if you cant beat them or cheat them defund themjoin the conversation   prothena announces appointment of dr gene g kinney as president chief executive officer and director nasdaqprta facebook google linkedin twitter email rss oct   previous release  next release pdf add to briefcase file is in briefcase prothena announces appointment of dr gene g kinney as president chief executive officer and director dublin ireland oct   globe newswire  prothena corporation plc nasdaqprta a latestage clinical biotechnology company focused on the discovery development and commercialization of novel protein immunotherapies announced today that gene kinney phd has been appointed president and chief executive officer of prothena  dr kinney has also been appointed to prothenas board of directors  the appointments come following the passing of prothenas cofounder president and ceo dr dale b schenk on september    gene is a wellknown and highly respected biotechnology executive who is uniquely qualified to lead prothena stated lars g ekman md phd chairman of the prothena board of directors he has worked closely with dale for many years and leads an extremely experienced and talented team  while we share their great sadness at the loss of our friend dale we are confident that the strategy established by the board of directors and management team under dales leadership will be advanced and that the team will continue to work closely with prothenas employees scientific collaborators and investors to forward the mission of delivering meaningful therapeutics to treat devastating diseases all of us at prothena are extremely saddened by the loss of our cofounder and friend dale stated dr kinney our team of incredibly talented employees will work every day to honor dales memory through a continued commitment to our core values of courage creativity and selflessness dale embodied these values and they drive our passion for developing important new therapies for patients prothena was founded on dales clear and compelling vision of advancing new medicines for dire and often untreatable diseases and we continue to be inspired by and find purpose in this vision  we will always be profoundly grateful for his friendship and leadership of course during this time our thoughts are with dales family and we will do everything we can to support them dr kinney worked with dr schenk since  first at elan and then at prothena when the company spun out of elan in  as a preclinical stage company and has since established itself as an integrated research development and commercial biotechnology company as a founding member of prothenas leadership team dr kinney was head of research and development and chief scientific officer and led the team responsible for advancing a robust pipeline into latestage clinical development as well as generating novel antibody targets in discovery dr kinney was recently named chief operating officer of prothena and had been leading the company since dr schenk began a medical leave of absence  prior to joining prothena in positions of increasing scope dr kinney has held responsibility for overseeing portfolio strategy leading rd teams and supporting commercial product launches dr kinney was senior vice president of pharmacological sciences at elan pharmaceuticals inc and held several senior rd positions not only at elan but also janssen alzheimer immunotherapy rd merck research laboratories and bristolmyers squibb and was an assistant professor at the emory university school of medicine dr kinney earned his ba from bloomsburg university and his ma and phd from florida atlantic university  about prothena prothena corporation plc is a global latestage clinical biotechnology company seeking to fundamentally change the course of progressive diseases with its clinical pipeline of novel therapeutic antibodies fueled by its deep scientific understanding built over decades of research in protein misfolding and cell adhesion — the root causes of many serious or currently untreatable amyloid and inflammatory diseases — prothena is establishing a fully integrated research development and commercial focus and has advanced several drug candidates into clinical studies while pursuing discovery of additional novel therapies  our pipeline of antibodybased product candidates targets a number of potential indications including al amyloidosis neod parkinsons disease and other related synucleinopathies prx inflammatory diseases including psoriasis and psoriatic arthritis prx and attr amyloidosis prx for more information please visit the companys website at wwwprothenacomcontacts investors tran nguyen cfo 7 irprothenacom media ellen rose head of communications  ellenroseprothenacom prothena announces appointment of gene g kinney as chief operating officer  thestreet action alerts plus access aapjim cramers best stocks for 7charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for 7 commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street prothena announces appointment of gene g kinney as chief operating officer globenewswire sep    pm edt dublin ireland sept   globe newswire  prothena corporation plc nasdaqprta a latestage clinical biotechnology company focused on the discovery development and commercialization of novel protein immunotherapies today announced the promotion of gene g kinney phd to the position of chief operating officer coo in this newly created position dr kinney will be responsible for an integrated research development and commercial organization and several additional key organizational functions within the company dr kinney also retains his title and responsibilities as chief scientific officer dr kinney had held the position of chief scientific officer and head of research and development since prothena was established in december  leading the team responsible for advancing a robust clinical pipeline into latestage clinical development as well as generating novel antibody targets in discovery genes appointment to this expanded role underscores not only his exceptional scientific and business leadership but also the exciting growth path we are setting for prothena commented dale schenk phd president and chief executive officer of prothena as one of our founding executive team members responsible for helping to establish the company and advance a pipeline of novel protein immunotherapies gene is uniquely qualified to guide our continued growth as a fully integrated research development and commercial organization i very much look forward to working with him on these critical efforts gene is a highly regarded creative and thoughtful leader who has played a key role in the success prothena has experienced to date noted lars g ekman md phd chairman of the prothena board of directors the prothena board is delighted to continue working with gene in this new leadership role dr kinney is an experienced biotechnology executive and has held positions across pharmaceutical biotechnology and academic organizations in positions of increasing scope dr kinney has held responsibility for overseeing portfolio strategy leading rd teams and supporting commercial product launches before joining prothena dr kinney was senior vice president of pharmacological sciences at elan pharmaceuticals inc where he held several senior roles in research and development from  through  between  and  dr kinney also served as head of nonclinical research for janssen alzheimer immunotherapy rd from  to  he was senior director head of central pharmacology and acting lead for bioanalytics  pathology at merck research laboratories dr kinney also held positions at bristolmyers squibb and was an assistant professor at the emory university school of medicine department of psychiatry and behavioral sciences if you liked this article you might like these are the best growth stocks right now in biotech top names armie margaret lee jul  7  pm edt  stocks you probably never heard of could catch fire soon six charts showing signs of smart money footprints roberto pedone jun  7  am edt prothena raises m to bring antiorgan failure drug to market the biotech company plans to commercialize its treatment for al amyloidosis a disease that causes protein to build up in the blood armie margaret lee mar  7  pm est biotech premarket movers karyopharm lexicon prothena karyopharm therapeutics falls  lexicon rises on drug approval armie margaret lee mar  7  am est trending walmart in focus amid horrific human trafficking incident in texas that causes nine deaths brutal reactions to alphabet and hasbro results show you need to be a trading mercenary stock futures inch higher but alphabets earnings cause concern alphabet slides after a soso quarter   things you must know before the market opens amazon tumbling almost  is not as crazy as it sounds advertising partners 7 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers gene g kinney phd – prothena you are here home  about  management  gene g kinney phd gene g kinney phdpresident and chief executive officer director dr kinney has served as our president and ceo since september  prior to being appointed to this position he was chief operating officer and chief scientific officer dr kinney is a member of prothena’s founding leadership team and between  and  held the position of chief scientific officer and head of research and development before joining prothena dr kinney held positions with elan pharmaceuticals inc including senior vice president of pharmacological sciences a position he held from  to  and vice president pharmacology a position he held from  to  while in those positions dr kinney also served as head of nonclinical research for janssen alzheimer immunotherapy rd before joining elan dr kinney held several senior positions at merck research laboratories and bristolmyers squibb and was an assistant professor at the emory university school of medicine dr kinney earned his ba from bloomsburg university and his ma and phd from florida atlantic university dr kinney has served on our board since september  menuabout us management board of directors partnering our history pipeline neod prx prx prx publications investors press releases events  presentations financials  filings sec filings quarterly results key ratios irish statutory financial statements corporate governance committee composition stock information historic stock lookup investment calculator analyst coverage patients amyloidosis parkinson’s disease inflammatory disease  psoriasis  psoriatic arthritis clinical trials compassionate use careers core values compensation and benefits opportunities contact us headquarters prothena corporation plc adelphi plaza upper george’s street dún laoghaire co dublin a t7 ireland information tel     fax     email infoprothenacom lars g ekman md phd richard t collier scroll to top prothena announces appointment of gene g kinney as chief operating officer  marketwatch bulletin mcdonalds shares gain as earnings report includes strong samestore sales rise » barnes  noble shares rocket  premarket after activist shareholder urges sale » investor alert new york markets open in market snapshot analyst ratings sept    pm edt prothena announces appointment of gene g kinney as chief operating officer  comments tweet new watchlist relevancelearn more want to see how this story relates to your watchlist just add items to create a watchlist now xaddprothena corp plc prta add create watchlist or cancel already have a watchlist log in globe newswire via comtex  dublin ireland sept   globe newswire  prothena corporation plc quoteszigman7composite prta   a latestage clinical biotechnology company focused on the discovery development and commercialization of novel protein immunotherapies today announced the promotion of gene g kinney phd to the position of chief operating officer coo in this newly created position dr kinney will be responsible for an integrated research development and commercial organization and several additional key organizational functions within the company dr kinney also retains his title and responsibilities as chief scientific officer dr kinney had held the position of chief scientific officer and head of research and development since prothena was established in december  leading the team responsible for advancing a robust clinical pipeline into latestage clinical development as well as generating novel antibody targets in discovery genes appointment to this expanded role underscores not only his exceptional scientific and business leadership but also the exciting growth path we are setting for prothena commented dale schenk phd president and chief executive officer of prothena as one of our founding executive team members responsible for helping to establish the company and advance a pipeline of novel protein immunotherapies gene is uniquely qualified to guide our continued growth as a fully integrated research development and commercial organization i very much look forward to working with him on these critical efforts gene is a highly regarded creative and thoughtful leader who has played a key role in the success prothena has experienced to date noted lars g ekman md phd chairman of the prothena board of directors the prothena board is delighted to continue working with gene in this new leadership role dr kinney is an experienced biotechnology executive and has held positions across pharmaceutical biotechnology and academic organizations in positions of increasing scope dr kinney has held responsibility for overseeing portfolio strategy leading rd teams and supporting commercial product launches before joining prothena dr kinney was senior vice president of pharmacological sciences at elan pharmaceuticals inc where he held several senior roles in research and development from  through  between  and  dr kinney also served as head of nonclinical research for janssen alzheimer immunotherapy rd from  to  he was senior director head of central pharmacology and acting lead for bioanalytics  pathology at merck research laboratories dr kinney also held positions at bristolmyers squibb and was an assistant professor at the emory university school of medicine department of psychiatry and behavioral sciences dr kinney earned his ba from bloomsburg university and his ma and phd from florida atlantic university about prothena prothena corporation plc is a global latestage clinical biotechnology company seeking to fundamentally change the course of progressive diseases with its clinical pipeline of novel therapeutic antibodies fueled by its deep scientific understanding built over decades of research in protein misfolding and cell adhesion  the root causes of many serious or currently untreatable amyloid and inflammatory diseases  prothena has advanced several drug candidates into clinical trials while pursuing discovery of additional novel therapies our pipeline of antibodybased product candidates targets a number of potential indications including al amyloidosis neod parkinsons disease and other related synucleinopathies prx and inflammatory diseases including psoriasis prx and attr amyloidosis prx for more information please visit the companys web site at wwwprothenacom  investors tran nguyen cfo 7 irprothenacom media ellen rose  ellenroseprothenacom this announcement is distributed by nasdaq corporate solutions on behalf of nasdaq corporate solutions clients the issuer of this announcement warrants that they are solely responsible for the content accuracy and originality of the information contained therein source prothena corporation plc via globenewswire copyright c  globe newswire all rights reserved quoteszigman7composite add to watchlist prta prothena corp plc us  us nasdaq  7   volume  july  7 p pe rationa dividend yieldna market cap billion rev per employee7 this story has  comments be the first to comment story conversation commenting faqs » most popular  the biggest dog in the dow might soon break free  oj simpson made over  while in prison and won’t have to give any of it to the goldman family  americans in this field have the highest rate of divorce by age   marketwatch first take alphabet earnings keep google investors in dark  a history of sears through highs and lows breaking insight the technical indicator charting a thirdquarter breakout sp  target projects to  mark robert powell this is why young people make terrible investment decisions the technical indicator charting the sp ’s bullish backdrop amid early thirdquarter cross currents robert powell how to fund a long retirement find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  am edt july  7 marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingcaterpillar mcdonalds stocks set to add about  points to dow industrials aseagate technologys stock plunges after profit and sales miss ceo change aneuralstem stock halted on news of midstage clinical trial miss 7afreeportmcmoran shares gain  after company swings to a profit in q ainvesting lessons from edward thorp quant pioneer and card counter awe’re reaching the dangerous ninth inning for commercial real estate aneuralstem shares halted premarket for news pending awhat the solar eclipse on aug  will mean for stocks amcdonalds shares rise after earnings revenue beat estimates aseagate technologys stock plunges 7 premarket after q results ceo transition abarnes  noble shares rocket  premarket after activist shareholder urges sale awells fargo released client data company discloses afreeport mcmoran q adj eps 7 cents factset consensus  cents afreeport mcmoran q eps  cents vs loss  cents afreeport mcmoran q revenue 7 bln vs  bln factset consensus 7 blne amcdonalds stock surges  premarket after q results amcdonalds q intl lead segment samestore sales up  factset consensus up  amcdonalds q us samestore sales up  factset consensus  amcdonalds q revenue  bln vs 7 bln factset consensus  bln amcdonalds q factset eps consensus  loading more headlines dow quoteszigman7realtime 7   nasdaq quoteszigmanrealtime    sp  quoteszigman7realtime    kiosk 7 7 the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml 7   alerts congakioskalertshtml  77  virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml   77 location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml  7 7 lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright  7 marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  gene g kinney phd  uc berkeley center for executive education jump to navigation linkscalendar client list careers search form search executive programscolumn certificate of business excellencemanagementthe berkeley executive leadership programnew manager boot campboot camp for experienced managersberkeley advanced global management programfinancial analysis for nonfinancial executivesinnovationventure capital executive programthe innovative organizationproduct managementcorporate business model innovationinsider entrepreneurshipstrategy in competitive marketscolumn leadershipthe berkeley executive leadership programhighimpact leadershipthe womens executive leadership programleading with ethics and compliancenew manager boot campboot camp for experienced managersbusiness leadership for it professionalsfinancial analysis for nonfinancial executivesstrategy in competitive marketsfinancefinancial analysis for nonfinancial executivesventure capital executive programthe executive program in gold reserves managementcolumn marketingproduct managementpricing for profitabilitythe innovative organizationcommunication and negotiationnegotiations and influencehighimpact leadershipexecutive coaching institutepersuasive communication strategyindustrythe executive program in gold reserves managementasean global leadership programcio instituteciso institutekfas innovation challengethe berkeley executive program in management indiacustomized solutionscolumn custom programscase studiesclient listcorporate sponsorshipcertificate of business excellenceaboutcolumn our methodologyhaas school of businessthe san francisco bay areaprogram accommodationslocal attractionsfaqswhat happens after i registeravailable discountsmeet our board of directorscontact gene g kinney phd dr gene kinney has over  years of neuroscience drug discovery experience and is currently the head of nonclinical research at janssen alzheimer immunotherapy rd and senior vice president pharmacological sciences at elan pharmaceuticals incjansen alzheimer immunotherapy janssen ai was formed as a subsidiary of johnson  johnson in september  following the acquisition of controlling interest in élan’s alzheimer immunotherapy program aip  in his current role dr kinney supervises a crossfunctional team of scientists focused on advancing our understanding of basic mechanisms surrounding the use of immunotherapeutic approaches for the treatment of alzheimers disease  in this capacity dr kinney leads the research area at janssen ai which includes nonclinical research dmpk and safetytoxicologydr kinney also retains a position at elan pharmaceuticals as senior vice president and head of pharmacological sciences  in this role dr kinney leads a team of discovery scientists towards the development of novel large and small molecule therapeutics in the field of neurodegeneration  pharmacological sciences incorporates several functional areas such as anatomy  pathology pharmacology dmpk and safetytoxicologydr kinney is a recognized leader in the field of alzheimer’s research and therapeutics  following the recent passage of federal law establishing the national alzheimer’s project act napa dr kinney has been involved with the formation of a national strategy to address the increasing burden of alzheimer’s disease through invited participation in leader’s engaged in alzheimer’s disease lead teamsprior to joining janssen alzheimer immunotherapy and elan dr kinney was senior director head of central pharmacology and acting lead for bioanalytics  pathology at the merck research laboratories located in west point pennsylvania  during his tenure at merck dr kinney contributed to the strategic direction and oversight of drug discovery activities and led a number of nonclinical discovery and clinical development programs targeted for the treatment of neurodegenerative eg alzheimer’s and parkinson’s disease and psychiatric conditions eg schizophrenia and depressiondr kinney has previously held positions at bristolmyers squibb where he led andor significantly contributed to a number of drug discovery programs in the areas of depression schizophrenia migraine stroke and alzheimer’s diseasecognition and was an assistant professor at the emory university school of medicine department of psychiatry and behavioral sciences center for executive education at the haas school of business  center st berkeley california 7 • usa phone 7 email executiveberkeleyedu connect with us   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext7 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext77 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext77 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext77 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext77 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext7 legal privacy  cookies  7 microsoft background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming we also search social networks this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip